The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 07, 2015

Filed:

Sep. 06, 2005
Applicants:

William H. Frey, Ii, White Bear Lake, MN (US);

John Randall Fawcett, Palo Alto, CA (US);

Inventors:

William H. Frey, II, White Bear Lake, MN (US);

John Randall Fawcett, Palo Alto, CA (US);

Assignee:

HealthPartners Research Foundation, Bloomington, MN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/70 (2006.01); A61K 31/6615 (2006.01); A61K 31/352 (2006.01); A61K 31/409 (2006.01); A61K 31/66 (2006.01); A61K 31/661 (2006.01); A61K 31/662 (2006.01); A61K 31/663 (2006.01); A61K 31/7072 (2006.01); A61K 31/7076 (2006.01); A61K 31/708 (2006.01); A61K 31/7084 (2006.01); A61K 31/7105 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/6615 (2013.01); A61K 31/352 (2013.01); A61K 31/409 (2013.01); A61K 31/66 (2013.01); A61K 31/661 (2013.01); A61K 31/662 (2013.01); A61K 31/663 (2013.01); A61K 31/7072 (2013.01); A61K 31/7076 (2013.01); A61K 31/708 (2013.01); A61K 31/7084 (2013.01); A61K 31/7105 (2013.01); A61K 45/06 (2013.01);
Abstract

Methods and compositions for increasing the efficacy of an agent that directly or indirectly affects a muscarinic receptor by administering a pyrophosphate analog. Methods and compositions for protecting a pharmacological agent in a formulation, comprising combining the pharmacological agent with at least one pyrophosphate analog. Methods and compositions for increasing the efficacy of a neurologic agent by administering at least one pyrophosphate analog. Methods and compositions for increasing the efficacy of an agent that neither directly nor indirectly affects a muscarinic receptor by administering at least one pyrophosphate analog.


Find Patent Forward Citations

Loading…